A groundbreaking study has uncovered how specific genetic mutations influence cancer treatment outcomes -- insights that could help doctors tailor treatments more effectively. The largest study of its ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Given the success of the previous Research Topic 'Exploring Small Molecule Inhibitors in Cardiovascular and Cerebrovascular Diseases', we are pleased to ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Breast cancer (BC) is the most common malignancy among females worldwide. Breast cancer is a highly heterogeneous malignant tumor which is constitutive of ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...

Pedal the Cause announces funding for eight new cancer research projects and a clinical trial at Siteman Cancer Center.

KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

This funding is intended to support the formation of Cancer Health Equity Research Centers (CHERCs) designed to target cancer health disparities that are unique to a local or regional community. We ...